Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
Young Kwang Chae(Johns Hopkins University), Francis J. Giles(Northwestern University)
Cited by 467
Related Papers
Repurposing metformin for cancer treatment: current clinical studies
|Oncotarget|2016|313
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial
|The Journal of Clinical Endocrinology & Metabolism|2019|116